CD274 and neoplasm: PD-L1 protein expression changes dynamically in the process of tumor progression, with a low positive staining rate, and immunotherapy is affected by several factors, which require us to conduct in-depth studies on the regulation mechanism of PD-L1 protein expression to improve the benefit of PD-L1 monotherapy [8].